You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Moodys
McKinsey
Merck

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PSN-375,963

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PSN-375,963?

PSN-375,963 is an investigational drug.

There have been 7 clinical trials for PSN-375,963. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2020.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Leukemia. The leading clinical trial sponsors are Sanofi, University of Alberta, and University of Pisa.

There are seventeen US patents protecting this investigational drug and one hundred and sixty-five international patents.

Recent Clinical Trials for PSN-375,963
TitleSponsorPhase
Topical Vancomycin Over Sternal Edge in Cardiac SurgeryNational Cheng-Kung University HospitalPhase 4
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of AlbertaN/A
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of TorontoN/A

See all PSN-375,963 clinical trials

Clinical Trial Summary for PSN-375,963

Top disease conditions for PSN-375,963
Top clinical trial sponsors for PSN-375,963

See all PSN-375,963 clinical trials

US Patents for PSN-375,963

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PSN-375,963   Start Trial Modulators of sphingosine phosphate receptors The Scripps Research Institute (La Jolla, CA)   Start Trial
PSN-375,963   Start Trial Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Arena Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
PSN-375,963   Start Trial Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level Arena Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Moodys
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.